Most Recent
SMBC can’t access King & Wood Mallesons docs in $34M case against Humm
SMBC has lost a bid for documents connected to King & Wood Mallesons opinions in its suit against fintech Humm linked to the Forum Finance fraud, with a court saying the Japanese bank did not share joint privilege over the material.
Alcoa wins transfer pricing dispute with Tax Office
Alcoa has won a transfer pricing dispute with the Tax Office, with a tribunal rejecting the ATO's novel argument that Alcoa was not dealing at arm's length in selling alumina to a distributor that bribed Bahraini government officials.
Sanofi loses challenge to Amgen patents for cholesterol-busting Repatha
Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.
Thomson Geer picks up Hogan Lovells life sciences team
A life sciences and regulatory expert and her team have joined Thomson Geer following the shuttering of Hogan Lovells' Australian practice.
Judge questions need for solicitors in Jaguar class action discovery process
A judge has questioned the need for solicitors in a class action against Jaguar to be involved in discovery of internal investigations by the car maker when a technical referee is to be appointed.
Jones Day lures enviro partner from Norton Rose Fulbright
A top environmental lawyer has joined Jones Day as a partner in the firm's government regulation practice.
WiseTech shareholder class action loses bid for early discovery
A judge has declined an early bid for broad discovery in a shareholder class action against tech firm WiseTech, after hearing it would require the production of "truckloads" of irrelevant material.
Jones Day grows corporate practice with partners from Hogan Lovells
Global law firm Jones Day has recruited two corporate partners from rival Hogan Lovells to join its transactions team in Sydney.
High Court ends Commonwealth’s quest for $325M over generic Plavix ban
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
Pacific Werribee centre owners get preliminary trial in $200M defects spat
The co-owners of Pacific Werribee shopping centre in Victoria have won their bid for a preliminary trial in a suit against Probuild Constructions and several engineering companies over $200 million in alleged structural defects.